Skip to main content
Neuland Labs
Menu
Search
Search
Main navigation
CDMO Services
CDMO Services sub-navigation
Small Molecules
Peptides
Generic APIs
Generic APIs sub-navigation
API Products
Download Brochure
Our Capabilities
Our Capabilities sub-navigation
Chemistry & Reactions
Peptide Technologies
Lifecycle Management (Phase-Appropriate Development)
Quality & Regulatory Compliance
Technology Transfer
Analytical Expertise
Process Safety & Engineering
Contact us
Search
Search
User account menu
Log in
Breadcrumb
Home
Unaudited Financial Results (Consolidated and Standalone) for Q3 FY 2024
By
admin
, 30 September, 2026
Quarterly Results
2023-24
PDF
signedbmoutcome08022024.pdf
(891.58 KB)
RSS feed